Klaas Daniël Kussendrager

Title: Klaas Daniël Kussendrager: Innovator in Anhydrous Lactose Agglomerates

Introduction

Klaas Daniël Kussendrager is a notable inventor based in Veghel, Netherlands. He has made significant contributions to the field of pharmaceutical excipients, particularly through his innovative work on anhydrous lactose agglomerates. His expertise and dedication to research have led to advancements that benefit moisture-sensitive applications in the pharmaceutical industry.

Latest Patents

Kussendrager holds a patent for "Anhydrous lactose agglomerates and the preparation thereof." This invention outlines a process for creating anhydrous lactose agglomerates, which involves subjecting essentially anhydrous lactose primary particles to a wet granulation step. The process operates at temperatures ranging from 30-100°C and utilizes a binder solution. The resulting agglomerates contain at least 50 wt% lactose crystallites and maintain a total water content of 0-1.0 wt%, adhering to the standards set by the Pharmacopoeia for anhydrous lactose excipients. These agglomerates exhibit excellent compactibility and flowability properties, making them particularly useful in moisture-sensitive applications.

Career Highlights

Klaas Daniël Kussendrager is associated with Campina Nederland Holding B.V., where he has been instrumental in developing innovative solutions in the field of lactose products. His work has not only advanced the understanding of lactose agglomerates but has also contributed to the overall improvement of excipients used in pharmaceuticals.

Collaborations

Kussendrager has collaborated with Bouwe Walsma, further enhancing the research and development efforts in their field. Their partnership has fostered innovation and has led to the successful implementation of new technologies in lactose processing.

Conclusion

Klaas Daniël Kussendrager's contributions to the field of anhydrous lactose agglomerates demonstrate his commitment to innovation and excellence. His work continues to impact the pharmaceutical industry positively, ensuring the availability of high-quality excipients for moisture-sensitive applications.